PARSIFAL

OFFICIAL TITLE: STUDY TO EVALUATE THE EFFICACY AND SAFETY OF PALBOCICLIB IN COMBINATION WITH FULVESTRANT OR LETROZOLE IN PATIENTS WITH ER+, HER2- LOCALLY ADVANCED OR METASTATIC BREAST CANCER.

PROJECT DETAILS

A RANDOMIZED, MULTICENTER, OPEN-LABEL, PHASE II TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF PALBOCICLIB IN COMBINATION WITH FULVESTRANT OR LETROZOLE IN PATIENTS WITH HER2 NEGATIVE, ER+ METASTATIC BREAST CANCER.

THIS IS AN INTERNATIONAL, RANDOMIZED, OPEN-LABEL, CONTROLLED, MULTICENTER PHASE II CLINICAL TRIAL TO INVESTIGATE AND COMPARE THE SAFETY AND EFFICACY OF PALBOCICLIB COMBINED WITH FULVESTRANT OR LETROZOLE IN WOMEN WITH ER+, HER2- LOCALLY ADVANCED OR METASTATIC BREAST CANCER.

 

PARSIFAL AT CLINICALTRIALS.GOV

TUMOR TYPE

PHASE

HER2+ EBC

II

486

52

Spain, France, Italy, UK, Germany, Russia, Czech Republic

N

SITES

COUNTRY

STATUS

Recruitment
Closed

ESMO  2016 – DOWNLOAD THE POSTER

PARSIFAL SITES

Hospital Universitari Vall D'Hebron

SPAIN

Instituto Valenciano de Oncología (IVO)

SPAIN

Hospital Universitario Reina Sofía

SPAIN

Institut Català d' Oncologia L'Hospitalet (ICO)

SPAIN

Hospital del Mar

SPAIN

Hospital Universitario Central de Asturias (HUCA)

SPAIN

Hospital Universitario Virgen del Rocío

SPAIN

Institut Català d' Oncologia Girona (ICO)

SPAIN

Hospital Universitari Sant Joan de Reus

SPAIN

Hospital Universitario Juan Ramón Jiménez

SPAIN

Complejo Hospitalario de Navarra

SPAIN

Hospital San Pedro de Alcántara

SPAIN

Hospital Universitario de Basurto

SPAIN

Hospital Clínico Universitario Lozano Blesa

SPAIN

Hospital Universitario Miguel Servet

SPAIN

Complejo Hospitalario Universitario de Santiago (CHUS)

SPAIN

Hospital Universitario La Paz

SPAIN

Hospital Provincial de Castellón

SPAIN

Instituto Oncológico Baselga - Hospital Quiron Salud Barcelona

SPAIN

Hospital Arnau de Vilanova de Valencia

SPAIN

Hôpital Tenon AP-HP

FRANCE

Institut Universitaire du Cancer Toulouse, Toulouse

FRANCE

Institut Curie

FRANCE

Centre Paul Strauss

FRANCE

Hopital Europeen Georges Pompidou

FRANCE

Fondazione IRCCS Istituto Nazionale dei Tumori

ITALY

Instituto Europeo di Oncologia

ITALY

AOU policlinico di Modena

ITALY

Ospedale San Gerardo

ITALY

Ospedale Antonio Perrino

ITALY

Istituti Ospitalieri Cremona

ITALY

Ospedale Guglielmo da Saliceto

ITALY

Azienda Ospedaliero-Universitaria Cittá de la Salute e della Scienza

ITALY

Azienda Ospedaliero- Universitaria di Cagliari

ITALY

Barts Cancer Institute

UK

Royal United Hospitals Bath NHS Foundation Trust

UK

Nottingham University Hospitals NHS Trust

UK

Abertawe Bro Morgannwg University Local Health Board, Singleton Hospital

UK

Queens Hospital, Barking, Havering and Redbridge University Hospitals NHS Trust

UK

Royal Cornwall Hospital NHS Trust

UK

The Christie NHS Foundation Trust

UK

National Center for Tumor Disease (NCT)

UK

Medizinisches Versorgungszentrum des Städtischen Klinikums Dessau (MVZ) - Frauenheilkunde

GERMANY

General University Hospital in Prague

CZECH REPUBLIC

Onkologická klinika Fakultní nemocnice Olomouc

CZECH REPUBLIC

Regional Clinical Oncology Hospital

RUSSIA

Moscow Clinical Scientific Center of the Moscow Health Department

RUSSIA

Republican Clinical Oncological Dispesary of Tatarstan Ministry of Health

RUSSIA

St. Petersburg Clinical Research and Practical Center of Specialized Types of Medical Care

RUSSIA